How To Protect A Modern Silicone Oil-Sensitive Biologic Drug For Self-Injection Of 2.25mL

Modern biologics, such as proteins and monoclonal antibodies, exert demanding requirements on their containment system, which can be difficult to navigate if a platform approach to packaging has been used in the past.

This platform approach does not always meet a customer's needs. One particular customer experienced expensive project delays when they selected their “tried and tested” large volume, glass syringe system to package a drug to be used in an auto-injector for self-administration.

This case study explores the details of the approach and how the customer was able to show better results and stability.